Press release
Post-operative Cataract Surgery Inflammation Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight
Post-operative Cataract Surgery Inflammation Market
To Know in detail about the Post-operative Cataract Surgery Inflammation market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Post-operative Cataract Surgery Inflammation Market Forecast
https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key facts of the Post-operative Cataract Surgery Inflammation Market Report:
• The Post-operative Cataract Surgery Inflammation market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In December 2024, VivaVision Biotech, a clinical-stage, privately owned biotechnology company dedicated to developing therapies for ocular diseases, today revealed positive topline results from its U.S. Phase 2 clinical trial of VVN461-CS-201. This potent non-steroidal dual JAK1/TYK2 immunomodulator is being developed to treat post-operative inflammation following cataract surgery.
• In December 2024, VivaVision Biotech, based in China, plans to move forward with its non-steroidal therapy, VVN461-CS-201 (VVN461), into a Phase III trial after the candidate successfully met the primary endpoint in a Phase II U.S. study focused on treating post-operative inflammation following cataract surgery.
• As per the National Eye Institute, cataracts affected 17.11% of the U.S. population in 2010. Additionally, over half of Americans aged 80 and above either have cataracts or have undergone surgery to remove them.
• According to the American Academy of Ophthalmology, over 24.4 million Americans aged 40 and above are affected by cataracts. By the age of 75, nearly half of the U.S. population has cataracts as of 2023.
• Key Post-operative Cataract Surgery Inflammation Companies: Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc., ASKA Pharmaceutical Co., Ltd., Bausch Health, Johnson & Johnson Services, Inc., Janssen Global Services, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Oculis, Formosa Pharmaceuticals, AimMaxTherapeutics, Salvat Laboratories, Azidus Brasil, Bausch & Lomb Incorporated, Laboratorios Poen, Oculis, Alcon Research, and others
• Key Post-operative Cataract Surgery Inflammation Therapies: OCS-01, APP13007, SVT15473, Ster, Bromfenac, Difluprednate, OCS-01 - Dexamethasone, Nepafenac Ophthalmic Suspension, and others
• The Post-operative Cataract Surgery Inflammation epidemiology based on gender analyzed that females were more affected by cataract than men
• The Post-operative Cataract Surgery Inflammation market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Post-operative Cataract Surgery Inflammation pipeline products will significantly revolutionize the Post-operative Cataract Surgery Inflammation market dynamics.
Post-operative Cataract Surgery Inflammation Overview
A cataract is a clouded spot in the eye's lens, which is clear and helps to concentrate light. Cataracts are quite frequent in older people. In actuality, more than half of all Americans 80 years of age and older either have cataracts or have undergone cataract surgery. Additionally, it is the leading global cause of blindness.
Get a Free sample for the Post-operative Cataract Surgery Inflammation Market Report
https://www.delveinsight.com/report-store/post-operative-cataract-surgery-inflammation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Post-operative Cataract Surgery Inflammation Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Post-operative Cataract Surgery Inflammation Epidemiology Segmentation:
The Post-operative Cataract Surgery Inflammation market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Post-operative Cataract Surgery Inflammation
• Prevalent Cases of Post-operative Cataract Surgery Inflammation by severity
• Gender-specific Prevalence of Post-operative Cataract Surgery Inflammation
• Diagnosed Cases of Episodic and Chronic Post-operative Cataract Surgery Inflammation
Download the report to understand which factors are driving Post-operative Cataract Surgery Inflammation epidemiology trends @ Post-operative Cataract Surgery Inflammation Epidemiology Forecast
https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Post-operative Cataract Surgery Inflammation Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Post-operative Cataract Surgery Inflammation market or expected to get launched during the study period. The analysis covers Post-operative Cataract Surgery Inflammation market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Post-operative Cataract Surgery Inflammation Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Post-operative Cataract Surgery Inflammation Therapies and Key Companies
• OCS-01: Oculis
• APP13007: Formosa Pharmaceuticals/AimMaxTherapeutics
• SVT15473: Salvat Laboratories
• Ster: Azidus Brasil
• Bromfenac: Bausch & Lomb Incorporated
• Difluprednate: Laboratorios Poen
• OCS-01 - Dexamethasone: Oculis
• Nepafenac Ophthalmic Suspension: Alcon Research
Discover more about therapies set to grab major Post-operative Cataract Surgery Inflammation market share @ Post-operative Cataract Surgery Inflammation Treatment Market
https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Post-operative Cataract Surgery Inflammation Market Strengths
• Advances in surgical techniques
• Advances in the understanding of ophthalmology
• Pipeline consists of late and early stage candidates.
Post-operative Cataract Surgery Inflammation Market Opportunities
• Uptake of potential emerging therapies with better clinical profile expected to be medium-fast due to the present unmet needs
• The side effects associated with therapies currently give a window of opportunity to pharma payer to bring in novel therapies.
Scope of the Post-operative Cataract Surgery Inflammation Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Post-operative Cataract Surgery Inflammation Companies: Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc., ASKA Pharmaceutical Co., Ltd., Bausch Health, Johnson & Johnson Services, Inc., Janssen Global Services, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Oculis, Formosa Pharmaceuticals, AimMaxTherapeutics, Salvat Laboratories, Azidus Brasil, Bausch & Lomb Incorporated, Laboratorios Poen, Oculis, Alcon Research, and others
• Key Post-operative Cataract Surgery Inflammation Therapies: OCS-01, APP13007, SVT15473, Ster, Bromfenac, Difluprednate, OCS-01 - Dexamethasone, Nepafenac Ophthalmic Suspension, and others
• Post-operative Cataract Surgery Inflammation Therapeutic Assessment: Post-operative Cataract Surgery Inflammation current marketed and Post-operative Cataract Surgery Inflammation emerging therapies
• Post-operative Cataract Surgery Inflammation Market Dynamics: Post-operative Cataract Surgery Inflammation market drivers and Post-operative Cataract Surgery Inflammation market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Post-operative Cataract Surgery Inflammation Unmet Needs, KOL's views, Analyst's views, Post-operative Cataract Surgery Inflammation Market Access and Reimbursement
To know more about Post-operative Cataract Surgery Inflammation companies working in the treatment market, visit @ Post-operative Cataract Surgery Inflammation Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Post-operative Cataract Surgery Inflammation Market Report Introduction
2. Executive Summary for Post-operative Cataract Surgery Inflammation
3. SWOT analysis of Post-operative Cataract Surgery Inflammation
4. Post-operative Cataract Surgery Inflammation Patient Share (%) Overview at a Glance
5. Post-operative Cataract Surgery Inflammation Market Overview at a Glance
6. Post-operative Cataract Surgery Inflammation Disease Background and Overview
7. Post-operative Cataract Surgery Inflammation Epidemiology and Patient Population
8. Country-Specific Patient Population of Post-operative Cataract Surgery Inflammation
9. Post-operative Cataract Surgery Inflammation Current Treatment and Medical Practices
10. Post-operative Cataract Surgery Inflammation Unmet Needs
11. Post-operative Cataract Surgery Inflammation Emerging Therapies
12. Post-operative Cataract Surgery Inflammation Market Outlook
13. Country-Wise Post-operative Cataract Surgery Inflammation Market Analysis (2020-2034)
14. Post-operative Cataract Surgery Inflammation Market Access and Reimbursement of Therapies
15. Post-operative Cataract Surgery Inflammation Market Drivers
16. Post-operative Cataract Surgery Inflammation Market Barriers
17. Post-operative Cataract Surgery Inflammation Appendix
18. Post-operative Cataract Surgery Inflammation Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Post-operative Cataract Surgery Inflammation Pipeline https://www.delveinsight.com/report-store/post-operative-cataract-surgery-inflammation-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
"Post-operative Cataract Surgery Inflammation Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Post-operative Cataract Surgery Inflammation market. A detailed picture of the Post-operative Cataract Surgery Inflammation pipeline landscape is provided, which includes the disease overview and Post-operative Cataract Surgery Inflammation treatment guidelines.
Post-operative Cataract Surgery Inflammation Epidemiology https://www.delveinsight.com/report-store/post-operative-cataract-surgery-inflammation-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's 'Post-operative Cataract Surgery Inflammation Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Post-operative Cataract Surgery Inflammation epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Related Reports:
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/chronic-pain-market
• Ventricular Fibrillation Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Adamantinoma Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market?utm_source=Medgadget&utm_medium=pressrelease&utm_campaign=kupr
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Chronic Lymphocytic Leukemia Cll Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
• Energy Based Aesthetic Devices Market: https://www.delveinsight.com/report-store/energy-based-aesthetic-devices-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Chronic Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Neuroprosthetics Market: https://www.delveinsight.com/blog/neuroprosthetics-market-analysis
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Palmar Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Acute Pain Market: https://www.delveinsight.com/report-store/acute-pain-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/external-defibrillators-market
• Dysthymia Market: https://www.delveinsight.com/report-store/persistent-depressive-disorder-market?utm_source=globenewswire&utm_medium=pressrelease&utm_campaign=spr
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Wet-age Related Macular Degeneration Market: https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Absssi Market Size: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-syndrome-market
• Central Pain Syndrome Market: https://www.delveinsight.com/report-store/central-pain-syndrome-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/blog/duchenne-muscular-dystrophy-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/audiology-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/ats-conference-coverage
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Post-operative Cataract Surgery Inflammation Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight here
News-ID: 4074546 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Cataract
Cataract Pipeline: Emerging Non-Surgical Solutions and Leading Companies Shaping …
The therapeutic landscape for Cataract, the leading cause of blindness globally, is undergoing a paradigm shift as researchers and biopharmaceutical companies explore non-surgical and disease-modifying alternatives to conventional cataract extraction surgery. Advances in molecular biology, oxidative stress modulation, and crystallin protein stabilization have opened new avenues for pharmacological intervention. Companies like Nacuity Pharmaceuticals, CGeneTech, and Plex Pharmaceuticals are pioneering efforts to develop novel agents aimed at delaying, halting, or reversing…
Cataract Surgery Devices Market - Innovation Meets Precision: Elevate Cataract S …
Newark, New Castle, USA: The "Cataract Surgery Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cataract Surgery Devices Market: https://www.growthplusreports.com/report/cataract-surgery-devices-market/7846
This latest report researches the industry structure,…
Intraocular Lens Implants for Cataract Market is Driven by the Increasing Incide …
The proposed Intraocular Lens Implants for Cataract Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.
The Intraocular Lens Implants for Cataract Market…
Potential Opportunities of Cataract Surgical Devices Market
The global cataract surgical devices market size is projected to reach USD 9.98 billion by the end of 2026. The high prevalence of cataract disorders will open up a huge potential for market growth. According to a report published by Fortune Business Insights, titled "Cataract Surgical Devices Market Size, Share & Industry Analysis, By Product Type (Phacoemulsification Systems, Femtosecond Laser, Intraocular Lenses, Ophthalmic Viscoelastic Devices & Other Consumables), By End-user…
Cataract Devices Market Forecast by 2015: QY Research, Inc.
According to a new report published by QY Research, Titled “Global Cataract Devices Market Professional Survey Report 2018,” by Company Profile Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development has been featured on QY Research.
Cataract Surgery is the removal of the eye’s clouded natural lens, and replacing it with an artificial lens that helps restore vision to the eye. Without removing the cataract surgically, most patients with…
Cataract Surgery Devices Market Opportunity Analysis, 2018-2026
Cataract surgery devices are used during the surgical procedures to treat cataract, which is an eye disorder that causes clouding of the lens leading to defects in vision. Cataract is one of the most widespread disease causing blindness and it reduces vision ability. Cataract is often encountered to develop slowly and affect either one or both the eyes.
Although cataract does not interfere with the eyesight in the early stages, it…
